LIVE MARKET TRACKER :   BSE SENSEX   33053.04      |    NSE NIFTY 10192.95    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Corporate  :  Glenmark Pharmaceuticals enters into exclusive agreement with Cyndea Pharma

Glenmark Pharmaceuticals enters into exclusive agreement with Cyndea Pharma (19-Jul-2017)

Glenmark Pharmaceuticals has entered into a development, license, manufacture and commercial supply agreement with Cyndea Pharma S.L., granting exclusive rights to use their technology for developing generic, soft-gelatin capsule formulations of certain pharmaceutical products.

Under this agreement, Glenmark receives exclusive rights to the United States and Canada markets for these soft-gelatin formulations in exchange for sharing development costs and profits from future sales. In addition, the agreement provides for the companies to add further soft-gelatin product candidates for development and commercialization, as new branded, soft gelatin, capsule-based drug products become available in the marketplace.

Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has several molecules in various stages of clinical development and is primarily focused in the areas of oncology, dermatology and respiratory.



Top News Today
Talwalkars commences construction of first leisure club in Pune
(13-Dec-2017)

Talwalkars commences construction of first leisure club in PuneTalwalkars Better Value Fitness has commenced the construction of its first leisure club in Wakad, Pune. Post the compliance of various statutory procedures, the club project has received necessary sanctions......click on news to read complete article.

NIIT features in '2017 Top 20 IT Training Company' list
(13-Dec-2017)

NIIT features in NIIT has been featured by Training Industry among 2017 Top 20 IT Training Company for the eighth consecutive year. Training Industry is one of the most trusted sources of information on the business of......click on news to read complete article.

Orchid Pharma receives ANDA approval for Aripiprazole Orally-Disintegrating Tablets
(13-Dec-2017)

Orchid Pharma receives ANDA approval for Aripiprazole Orally-Disintegrating TabletsOrchid Pharma has received ANDA approval from USFDA for Aripiprazole Orally-Disintegrating Tablets USP, 10 mg and 15 mg. Aripiprazole Orally-Disintegrating Tablets are atypical antipsychotic, indicated......click on news to read complete article.

International Stock News
US markets closed higher on Monday
(12-Dec-2017)

US markets closed higher on MondayThe US markets closed higher on Monday, with the S&P 500 index and Dow industrials closing at records on the back of a rally in telecommunications and technology shares. Wall Street shrugged off......click on news to read complete article.

Asian markets trade higher in early deals on Monday
(11-Dec-2017)

Asian markets trade higher in early deals on MondayAsian equity benchmark indices are trading higher in the early deals on Monday, lifted by encouraging employment data from the US that took the Standard & Poor's 500 Index to its third straight......click on news to read complete article.

US markets end at record highs on upbeat jobs data
(09-Dec-2017)

US markets end at record highs on upbeat jobs dataThe US markets traded with traction and ended near record high levels on Friday, as traders reacted positively to the closely watched monthly jobs report. The continued advance by stocks came following......click on news to read complete article.

 

     
  
Recent Corporate News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.